Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
122.7 SEK | +1.40% |
|
-6.34% | -32.77% |
07-01 | Surgical Science Sweden AB Appoints Tom Englund as New CEO, Effective October 1, 2024 | CI |
05-15 | Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- SUS Stock
- News Surgical Science Sweden AB